Effective treatments exist to improve the sexual health of men with erectile dysfunction (ED), yet research shows that many do not seek medical care or counseling for their condition. New research led by Dr. Ryan Flannigan found this could be rectified among men treated for prostate cancer by drawing more attention and referrals to the Sexual Rehabilitation Clinic (SRC).
With several treatments now available to care for the most urgent and severe cases of COVID-19, researchers are setting their sights on a potential intervention for the early stages of the virus.
Vancouver Coastal Health Research Institute clinician-scientist Dr. Sara Belga is investigating whether ciclesonide, a common anti-inflammatory drug, could help speed up recovery, and put a stop to disease progression and potential hospitalization among patients with mild COVID-19.
Preventable adverse drug events (pADE) are behind upwards of 10 per cent of hospital admissions. Reducing this figure to zero is behind Dr. Jane de Lemos’s research, which lays out a blueprint for checks and balances that can curtail hospitalizations from pADEs, as well as approaches to better inform and empower patients.
Following promising study results on the effectiveness of bendamustine and rituximab (BR) for treating mantle cell lymphoma in a clinical trial setting, researchers have now discovered that the combined treatment has similar effectiveness in a general patient population.
Bendamustine is a type of chemotherapy medication that kills fast-growing cells in the body, such as cancer cells. And rituximab is an antibody therapy that works to deplete B-cells.
Sleep apnea can be a pain in the neck for sufferers and their significant others. It can also increase the risk of developing other harmful health conditions. A new National Institutes of Health-funded study is delving deeper into individuals’ biological traits using state-of-the-art genetic and epigenetic sequencing, along with other approaches, in an effort to improve and extend the lives of people with obstructive sleep apnea (OSA).
A greater understanding of how COVID-19 affects people individually has researchers calling for a more targeted and cross-disciplinary approach to medical research and patient care.
“There can be a tendency in the health care field to operate in silos,” says Dr. Mypinder Sekhon, a Vancouver Coastal Health Research Institute (VCHRI) scientist and the lead author of a editorial on the COVID-19 cytokine storm syndrome (CSS) controversy that was published in the European Respiratory Journal.
Older Canadians tend to spend more time sitting than any other age group, which can impact both their physical and mental health. Despite this, researchers have discovered that seniors who are more physically active were less likely to have the characteristic thinning of the cerebral cortex that often goes hand-in-hand with cognitive decline.
A small molecule that packs a big anti-inflammation activation punch may provide relief to the millions of individuals around the world who suffer from ulcerative colitis and other inflammation-related diseases, according to the findings of a new study published in iScience.
